Krebs Biochemicals & Industries Limited

Board approved Scheme of Amalgamation merging Krebs Biochemicals into Ipca Laboratories, effective 1st April 2026. Share exchange ratio set at 7 Ipca shares for every 200 Krebs shares held, with no ca